Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Hollis Eden Pharmaceuticals Inc /de/ (HEPH) since 2011 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Hollis Eden Pharmaceuticals Inc /de/. Table 2 shows the detailed insider transactions. This company's CIK number is 899394.
Total stock buying since 2011: $11,250.
Total stock sales since 2011: $0.
Total stock option exercises since 2011: $0.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2011 | 75,000 | $11,250 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2011-10 | 75,000 | $11,250 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2011-10-28 | Frincke James M (CEO) | Buy | 25,000 | .16 | 4,000 |
| 2011-10-27 | Frincke James M (CEO) | Buy | 25,000 | .16 | 4,000 |
| 2011-10-18 | Frincke James M (CEO) | Buy | 25,000 | .13 | 3,250 |
Insider trading activities including stock purchases, stock sales, and option exercises of HEPH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Hollis Eden Pharmaceuticals Inc /de/ (symbol HEPH, CIK number 899394) see the Securities and Exchange Commission (SEC) website.